As of May 27
| +0.40 / +1.78%|
The 7 analysts offering 12-month price forecasts for Sagent Pharmaceuticals Inc have a median target of 29.00, with a high estimate of 35.00 and a low estimate of 27.00. The median estimate represents a +26.75% increase from the last price of 22.88.
The current consensus among 9 polled investment analysts is to Hold stock in Sagent Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.